Company Filing History:
2 out of 220 
2 out of 1,323 
1 out of 832,891 Years Active: 2000-2005
Title: **The Innovative Journey of Nicholas R. Staten**
Introduction
Nicholas R. Staten, an accomplished inventor based in St. Louis, MO, has made significant contributions to the field of biotechnology through his innovative work. With a remarkable portfolio of five patents, Staten has focused on developing novel multifunctional proteins that enhance hematopoietic activities, showcasing his commitment to advancing medical science.
Latest Patents
Staten's recent patents reflect his inventive spirit and scientific expertise. One of his notable patents, titled "Multi-functional chimeric hematopoietic receptor agonists," discloses the development of novel multi-functional chimeric hematopoietic receptor agonist proteins, along with the DNAs that encode these proteins. This patent details methods of making and using these proteins, which hold great potential for therapeutic applications.
Another significant patent, "Fused G-CSF and IL-3 proteins and uses thereof," introduces additional multi-functional hematopoietic receptor agonist proteins and methods related to their production and utilization. Both patents represent important advancements in the understanding and application of hematopoietic receptor modulators in medical treatments.
Career Highlights
Throughout his career, Staten has worked with esteemed companies, including Pharmacia Corporation and G.D. Searle & Company. His tenure at these organizations allowed him to refine his skills and knowledge, positioning him as a significant figure in the biotechnology industry.
Collaborations
Staten has collaborated with notable colleagues, including Charles A. McWherter and Yiqing Feng. These partnerships have likely fostered a dynamic exchange of ideas and insights, enhancing the innovation process and contributing to the successful development of their groundbreaking patents.
Conclusion
Nicholas R. Staten’s contributions to the realm of biotechnology through his innovative patents signify his role as a leading inventor. His dedication to the advancement of hematopoietic receptor technology not only reflects his expertise but also showcases the potential impact of his work on future therapeutic developments. Through collaboration and innovation, Staten continues to pave the way for new scientific breakthroughs.